Nifty Pharma PB	4.6
Nifty Pharma PE	33.4
Nifty Pharma DIV	0.7
Nifty Pharma EPS	641.6

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Biocon Ltd.

25 Sep 2025

343.90

0.85%

Company Update

Biocon Ltd - 532523 - Announcement Under Regulation 30 - Receipt Of Show Cause Notice

BSE India

Announcement under Regulation 30 - Receipt of show cause notice

pdf

Piramal Pharma Ltd.

25 Sep 2025

196.59

2.84%

Broker's call: Piramal Pharma (Add)

Business Line

InCred Equities

Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr

Wockhardt Ltd.

25 Sep 2025

1495.80

-1.33%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Pursuant to Regulation 30 of Listing Regulation, please find enclosed Press Release - "Prestigious Medical and Public Health Journal " The Lancet Regional Health" Publishes Pivotal Phase 3 Clinical Study on Miqnaf (Nafithromycin)- A Landmark for India''s Antibiotic Innovation".

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5437.50

0.23%

SAST

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

BSE India

This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended 30th September, 2025 are communicated to the Stock Exchanges.

pdf

Zydus Lifesciences Ltd.

25 Sep 2025

989.35

0.76%

Company Update

Zydus Lifesciences Ltd - 532321 - Receipt Of Order From Commissioner Of CGST, Ahmedabad

BSE India

Receipt of order from Commissioner of CGST, Ahmedabad

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5437.50

0.23%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 30th September, 2025. Accordingly, Mr. Amit Ghare shall cease to hold Senior Management Position of the Company effective from the said date i.e 30th September, 2025.

pdf

Wockhardt Ltd.

25 Sep 2025

1495.80

-1.33%

SAST

Wockhardt Ltd - 532300 - Closure of Trading Window

BSE India

Pursuant to Company''s Code of Conduct for regulating, monitoring and reporting trading by designated persons, the Trading Window for dealing in equity shares of the Company will be closed from 1st October, 2025 until 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September, 2025

pdf